Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Immunogenicity and Safety of Zostavax in Rheumatoid Arthritis Patients Using Abatacept

Trial Profile

The Immunogenicity and Safety of Zostavax in Rheumatoid Arthritis Patients Using Abatacept

Recruiting
Phase of Trial: Phase II

Latest Information Update: 07 Feb 2019

At a glance

  • Drugs Varicella zoster virus vaccine live (Primary)
  • Indications Herpes zoster; Varicella zoster virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Feb 2019 Last checked against ClinicalTrials.gov: US National Institutes of Health
    • 30 Jan 2019 Planned End Date changed from 1 Jun 2019 to 1 Dec 2020.
    • 30 Jan 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top